# Evaluation of Use of Diagnostic AI for Lung Cancer in Practice

> **NCT03780582** · NA · UNKNOWN · sponsor: **Ensemble Group Holdings, LLC** · enrollment: 15 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **BEHAVIORAL:** AI-human interaction

## Key facts

- **NCT ID:** NCT03780582
- **Lead sponsor:** Ensemble Group Holdings, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-14
- **Primary completion:** 2019-12-15
- **Final completion:** 2019-12-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03780582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03780582, "Evaluation of Use of Diagnostic AI for Lung Cancer in Practice". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03780582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*